Curated industry list

Overvalued Stocks in Pharmaceuticals on NASDAQ

Explore Overvalued Stocks in Pharmaceuticals on NASDAQ. Compare qualifying stocks using fair value, valuation, financial quality, analyst expectations, and market data.

Cumberland Pharmaceuticals Inc (CPIX)
Fair Value-26.4% Downside Overvalued Market Cap116.4 M P/E-15.3x Yield0.0% HealthGood
  NASDAQ Featured in Overvalued Stocks High-Momentum Stocks Technical Strength Leaders
Lexicon Pharmaceuticals Inc (LXRX)
Fair Value-31.6% Downside Overvalued Analyst52.6% Upside Market Cap1.106 B P/E-42.1x Yield0.0% HealthGreat
  NASDAQ Featured in Overvalued Stocks Rapid Revenue Growth High-Momentum Stocks High-Growth Small-Cap Stocks Small-Cap Stocks
Ligand Pharmaceuticals Incorporated (LGND)
Fair Value-20.1% Downside Overvalued Analyst10.4% Upside Market Cap5.959 B P/E39.0x Yield0.0% HealthGreat
  NASDAQ Featured in Overvalued Stocks
Nektar Therapeutics (NKTR)
Fair Value-38.8% Downside Overvalued Analyst109.6% Upside Market Cap2.458 B P/E-15.6x Yield0.0% HealthFair
  NASDAQ Featured in Overvalued Stocks
Omeros Corporation (OMER)
Fair Value-40.4% Downside Overvalued Analyst160.9% Upside Market Cap936.5 M P/E10.9x Yield0.0% HealthGood
  NASDAQ Featured in Overvalued Stocks High-Beta Stocks Small-Cap Stocks
Talphera Inc (TLPH)
Fair Value-26.1% Downside Overvalued Analyst134.6% Upside Market Cap70.584 M P/E-4.9x Yield0.0% HealthFair
  NASDAQ Featured in Overvalued Stocks
Eloxx Pharmaceuticals Inc (ELOX)
Fair Value-37.6% Downside Overvalued Analyst132.1% Upside Market Cap74.389 M P/E-9.0x Yield0.0% HealthGood
  NASDAQ Featured in Overvalued Stocks
Q/C Technologies Inc (QCLS)
Fair Value-22.6% Downside Overvalued Market Cap23.011 M P/E-1.6x Yield0.0% HealthFair
  NASDAQ Featured in Overvalued Stocks
Sol Gel Technologies Ltd (SLGL)
Fair Value-26.3% Downside Overvalued Analyst119.3% Upside Market Cap276.2 M P/E-275.0x Yield0.0% HealthGreat
  NASDAQ Featured in Overvalued Stocks Technical Strength Leaders
Aquestive Therapeutics Inc (AQST)
Fair Value-20.7% Downside Overvalued Analyst136.4% Upside Market Cap469.2 M P/E-6.8x Yield0.0% HealthFair
  NASDAQ Featured in Overvalued Stocks Small-Cap Stocks
ATAI Beckley Inc (ATAI)
Fair Value-32.9% Downside Overvalued Analyst32.8% Upside Market Cap2.656 B P/E-4.0x Yield0.0% HealthFair
  NASDAQ Featured in Overvalued Stocks High-Momentum Stocks Under $10 per Share
Crinetics Pharmaceuticals Inc (CRNX)
Fair Value-8.2% Downside Fair Analyst1.8% Upside Market Cap8.895 B P/E-17.8x Yield0.0% HealthFair
  NASDAQ Featured in Overvalued Stocks High-Beta Stocks High-Momentum Stocks High-Beta Momentum
Definium Therapeutics Inc (DFTX)
Fair Value-26.3% Downside Overvalued Analyst35.1% Upside Market Cap5.618 B P/E-24.8x Yield0.0% HealthFair
  NASDAQ Featured in Overvalued Stocks
Edgewise Therapeutics Inc (EWTX)
Fair Value-26.7% Downside Overvalued Analyst10.9% Upside Market Cap4.81 B P/E-27.5x Yield0.0% HealthGood
  NASDAQ Featured in Overvalued Stocks
Enliven Therapeutics Inc (ELVN)
Fair Value-43.6% Downside Overvalued Analyst12.1% Upside Market Cap4.267 B P/E-42.2x Yield0.0% HealthGreat
  NASDAQ Featured in Overvalued Stocks
Oculis Holding AG (OCS)
Fair Value-20.7% Downside Overvalued Analyst199.6% Upside Market Cap724.1 M P/E-6.2x Yield0.0% HealthFair
  NASDAQ Featured in Overvalued Stocks Small-Cap Stocks
Regencell Bioscience Holdings Ltd (RGC)
Fair Value-47.8% Downside Overvalued Market Cap2.998 B P/E-412.6x Yield0.0% HealthFair
  NASDAQ Featured in Overvalued Stocks High-Beta Stocks
Trevi Therapeutics Inc (TRVI)
Fair Value-43.9% Downside Overvalued Analyst40.4% Upside Market Cap2.662 B P/E-58.1x Yield0.0% HealthGood
  NASDAQ Featured in Overvalued Stocks High-Beta Stocks High-Momentum Stocks High-Beta Momentum
Agomab Therapeutics Nv (AGMB)
Fair Value-23.0% Downside Overvalued Analyst130.4% Upside Market Cap725.4 M P/E-8.1x Yield0.0% HealthFair
  NASDAQ Featured in Overvalued Stocks Small-Cap Stocks
Alumis Inc (ALMS)
Fair Value-35.3% Downside Overvalued Analyst47.9% Upside Market Cap3.458 B P/E-14.6x Yield0.0% HealthFair
  NASDAQ Featured in Overvalued Stocks
Amylyx Pharmaceuticals Inc (AMLX)
Fair Value-30.8% Downside Overvalued Analyst17.0% Upside Market Cap2.432 B P/E-16.2x Yield0.0% HealthFair
  NASDAQ Featured in Overvalued Stocks Small-Cap Stocks
AN2 Therapeutics Inc (ANTX)
Fair Value-30.4% Downside Overvalued Analyst54.1% Upside Market Cap213.9 M P/E-6.1x Yield0.0% HealthGreat
  NASDAQ Featured in Overvalued Stocks High-Momentum Stocks
Bioage Labs Inc (BIOA)
Fair Value37.1% Upside Undervalued Analyst263.2% Upside Market Cap497.9 M P/E-5.4x Yield0.0% HealthFair
  NASDAQ Featured in Overvalued Stocks High-Beta Stocks Small-Cap Stocks
LB Pharmaceuticals Inc (LBRX)
Fair Value-39.6% Downside Overvalued Analyst1.9% Upside Market Cap1.29 B P/E-33.2x Yield0.0% HealthGreat
  NASDAQ Featured in Overvalued Stocks High-Growth Small-Cap Stocks Small-Cap Stocks
NervGen Pharma Corp (NGEN)
Fair Value-28.3% Downside Overvalued Analyst531.2% Upside Market Cap176.6 M P/E-5.9x Yield0.0% HealthWeak
  NASDAQ Featured in Overvalued Stocks
Polaryx Therapeutics Inc (PLYX)
Fair Value-40.9% Downside Overvalued Analyst257.1% Upside Market Cap105.6 M P/E-16.3x Yield0.0% HealthWeak
  NASDAQ Featured in Overvalued Stocks
Rapport Therapeutics Inc (RAPP)
Fair Value-27.1% Downside Overvalued Analyst38.8% Upside Market Cap2.018 B P/E-19.0x Yield0.0% HealthGood
  NASDAQ Featured in Overvalued Stocks High-Beta Stocks High-Beta Momentum Small-Cap Stocks
SpyGlass Pharma Inc (SGP)
Fair Value-37.8% Downside Overvalued Analyst90.0% Upside Market Cap806.1 M P/E-18.0x Yield0.0% HealthGreat
  NASDAQ Featured in Overvalued Stocks Small-Cap Stocks
Structure Therapeutics Inc ADR (GPCR)
Fair Value-20.3% Downside Overvalued Analyst107.5% Upside Market Cap3.528 B P/E-21.1x Yield0.0% HealthFair
  NASDAQ Featured in Overvalued Stocks
Turn Therapeutics Inc (TTRX)
Fair Value-45.4% Downside Overvalued Analyst175.7% Upside Market Cap283.6 M P/E-73.2x Yield0.0% HealthFair
  NASDAQ Featured in Overvalued Stocks
Zhengye Biotechnology Holding Ltd (ZYBT)
Fair Value-45.9% Downside Overvalued Market Cap60.661 M P/E-5.9x Yield0.0% HealthWeak
  NASDAQ Featured in Overvalued Stocks
Explore listed stocks on NASDAQ with company information and fair value data.